The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Top Cited Papers
- 9 January 2009
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 8 (2) , 151-157
- https://doi.org/10.1016/s1474-4422(08)70295-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)PLoS Medicine, 2008
- Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric MedicationsAmerican Journal of Psychiatry, 2007
- Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal studyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's DiseaseNew England Journal of Medicine, 2006
- Neuroleptic drugs in dementia: benefits and harmNature Reviews Neuroscience, 2006
- Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trialBMJ, 2006
- Global prevalence of dementia: a Delphi consensus studyPublished by Elsevier ,2006
- Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialBMJ, 2005
- A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With DementiaThe Journal of Clinical Psychiatry, 2004
- Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's diseaseBiological Psychiatry, 1991